With a MCap of $ 260 m + cash + 30 yrs mine + Chinese JV + infrastructure + 68 % fine + Mplant = T/O soon from major !Wait and see !
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%